The epilepsy drugs supplied to government hospitals in Delhi have been found “spurious”. The revelation has come to fore after the samples of an epilepsy drug collected from a Delhi government facility were found spurious in a test conducted at a government laboratory. The test report of the Regional Drugs Testing Laboratory (RDTL) in Chandigarh revealed that Sodium valproate, an antiepileptic medication that controls seizures or fits, has “not met the standard quality”. The report was issued on December 22. The Vigilance Department has already directed to remove five drugs from the supplies are amlodipine, levetiracetam, pantoprazole, cephalexin and dexamethasone. These drugs are found not to standard quality during laboratory tests.
The test report stated that the sample was “not of standard quality as defined in the Drugs and Cosmetics Act, 1940…” as it did not conform to the “claim as per IP 2022 in respect to the Dissolution of Sodium Valproate.”
